|
Friday, April 28
5:00pm–6:00pm
1610A—Thrombosis—Going with the Flow:
Anticoagulation Issues in Children with Congenital Heart
Disease
ASPHO Workshop
Golden Gate Hall B2-3, SF Marriott
Chairs: Patricia Massicotte, University of Alberta Hospital, Edmonton,
AB, Canada; and Lori Luchtman-Jones, Washington University,
St. Louis, MO
Warfarin is commonly used in
children with congenital heart disease (CHD). There are many
challenges with the use of this anticoagulant in children.
Ultimate dosing depends on the individuals genetic
composition. Child-focused education on warfarin will improve
compliance, efficacy and safety. The hematologist with
expertise in anticoagulation can provide child-focused
education on anticoagulation and offer the cardiovascular team
management solutions for managing the complex issues
associated with anticoagulation in children with CHD.
-
Case Study and Discussion
Therese Giglia, Schneider Children's Hospital, New Hyde Park, NY
-
Child-Focused Education Package:
Warfarin
Mary Bauman, Stollery Children's Hospital, Edmonton, AB, Canada
-
Pharmacogenomics of Warfarin
Lori Luchtman-Jones, Washington University, St. Louis, MO
-
Keep the Flow: Hematologists as
Part of the Cardiovascular Team in Children with
Congenital Heart Disease
Therese Giglia, Schneider Children's Hospital, New Hyde Park, NY
-
Panel Discussion
Saturday, April 29
8:00am–11:00am
2100—Adult Stem Cells—A Primer for the
Clinician
PAS/ASPHO Mini Course
Room 3014, Moscone West
Chairs: Jakub Tolar, University of Minnesota, Minneapolis, MN; and
Mervin C. Yoder, Jr., Indiana University School of Medicine,
Indianapolis, IN
Target Audience:
Hematologists/oncologists, endocrinologists, basic scientists
and neurologists.
Adult stem cells represent a
technology that is being intensively investigated currently,
and this research may have wide implications for human health.
This mini course will focus on recent research and potential
applications in human health.
-
Introduction
Jakub Tolar, University of Minnesota, Minneapolis, MN
Mervin C. Yoder, Indiana
University School of Medicine, Indianapolis, IN
-
Multipotent Adult Progenitor
Cell: Hype or Reality?
Catherine M. Verfaillie, University of Minnesota, Minneapolis, MN
-
Mesenchymal Stem Cell: Harnessing
the Power of Adult Stem Cells To Repair Tissues
Darwin Prockop, Tulane University Health Science Center, New Orleans,
LA
-
Hierarchy of Endothelial
Progenitors in Human Blood and Blood Vessels
David A. Ingram, Indiana University School of Medicine, Indianapolis,
IN
-
Cancer Stem Cell: Concept of
Human Leukemic Development
Craig T. Jordan, James P. Wilmot Cancer Center, University of Rochester
School of Medicine, Rochester, NY
Sponsored jointly by
the American Society of Pediatric Hematology/Oncology and the
Pediatric Academic Societies
8:00am–11:00am
2125—New Considerations for the Growth Rate
of the Preterm Infant: Too Fast or Not Fast Enough?—A Review
of the Evidence
PAS Mini Course
Room 3002-3008, Moscone West
Chairs: Frank R. Greer, University of Wisconsin, Madison, WI; and
William W. Hay, Jr., University of Colorado, Aurora, CO
Target Audience: Neonatologists,
hospitalists who take care of preterm infants, nutritionists
and general pediatricians.
Recent nutritional emphasis in
the NICU has been to achieve the normal intrauterine growth
rate with more aggressive nutritional support for the low
birth weight infant. In general, this has been difficult to
achieve, and new evidence from long-term follow up studies
shows that preterm infants are at an increased risk of
developing the metabolic syndrome including obesity, type 2
diabetes and cardiovascular disease. This implies that the
organs in the early life of the preterm infant may be
programmed adversely by nutritional therapy. This raises the
questions of how fast these infants should grow (including
catch up growth), the importance of the composition of this
growth and the urgency for defining the necessary balance
between growth of the brain and the rest of the body.
Ultimately, providers may want to revise the long-term and
short-term goals for feeding very low birth weight or
extremely low birth weight infants. This mini course will
present evidence to help answer these questions and provide
discussion about related practice recommendations.
-
Overview
Frank R. Greer, University of Wisconsin, Madison, WI
William W. Hay, University of
Colorado Health Sciences Center, Aurora, CO
-
Macronutrient Requirements for
Growth of Preterm Infants—Upper and Lower Limits
(Energy, Fat, CHO, Protein)
Scott C. Denne, Indiana University School of Medicine, James Whitcomb
Riley Hospital, Indianapolis, IN
-
Aggressive Nutritional Support of
the Preterm Infant Revisited—Evidence for Efficacy and
Safety
Patti J. Thureen, University of Colorado Health Sciences Center,
Denver, CO
-
Adverse Outcomes of Rapid Somatic
Growth and Alterations of Body Composition in the Low
Birth Weight Infant
Frank R. Greer, University of Wisconsin, Madison, WI
-
Fatty Acids and Neuronal
Development
Susan E. Carlson, University of Kansas Medical Center, Kansas City, KS
-
Iron and Development of the Brain
Michael K. Georgieff, University of Minnesota School of Medicine,
Minneapolis, MN
-
Nutritional Influences on
Structural and Functional Maturation of the Developing
Brain During Extended Postnatal Period
Steve H. Zeisel, The University of North Carolina, Chapel Hill, NC
8:00am–11:00am
2130—Newborn Hearing Screening: From the
Bedside to Beyond
PAS/PIDS Mini Course
Room 3010, Moscone West
Chairs: Mark R. Schleiss and Lisa Ann Schimmenti, University of
Minnesota Medical School, Minneapolis, MN
Target Audience: General
pediatricians, geneticists and infectious disease specialists.
Sensorineural hearing loss (SNHL)
in infants is the most common birth defect, and early
detection improves outcome. Evidence from the CDC reveals that
less than one half of screened babies are followed up. One
possible reason is the low positive predictive value of
bedside screening. There is a critical need to augment current
strategies to prevent late diagnosis of SNHL. One solution is
to propose second-tier testing for the most common causes of
SNHL, as the most common causes of newborn hearing loss are
infectious and genetic. Of infectious causes, cytomegalovirus
(CMV) is the most common. Evidence of CMV infection can be
found in 1% of newborns, with 10–15% developing hearing loss
or other CNS abnormalities. Of the genetic causes, mutations
in GJB2/GJB6 are the most common and are identified in up to
one half of individuals with SNHL. The goal of this program
will be to examine evidence for inclusion of infectious and
genetic screening to augment current newborn screening
protocols.
-
Diagnostic Evaluation and
Management of Childhood Hearing Loss
Margaret Alene Kenna, Children's Hospital Boston, Boston, MA
-
Range of Mutations in
GJB2-Associated Hearing Loss
Lisa Ann Schimmenti, University of Minnesota Medical School,
Minneapolis, MN
-
Congenital Cytomegalovirus
Infection and Hearing Loss
Karen B. Fowler, University of Alabama at Birmingham, Birmingham, AL
-
Newborn Hearing Screening:
Audiologic Assessment
Yvonne Sininger, University of California Los Angeles, Los Angeles, CA
Sponsored jointly by
the Pediatric Infectious Diseases Society and the Pediatric
Academic Societies
9:00am–11:00am
2196—Modulators of Bronchopulmonary
Dysplasia
PAS Platform Session
Room 3003-3005, Moscone West
Chairs: Suhas G. Kallapur and Lawrence M. Nogee
Supported by an unrestricted educational grant from Dey,
L.P.
10:30am–12:30pm
2315—Brain Metabolism and Injury:
Mechanisms of Neuronal Injury and Neuroprotection
PAS Poster Symposium
Room 3024, Moscone West
Chairs: John D.E. Barks and Jeremy D. Marks
10:30am–12:30pm
2340—Necrotizing Enterocolitis
PAS Platform Session
Room 3022, Moscone West
Chairs: Cheryl E. Gariepy and B U.K. Li
12:00pm–3:00pm
2505—Embryonic Stem Cells: A Primer for
Clinicians
PAS Mini Course
Room 3014, Moscone West
Chair: Michael T. Longaker, Stanford University, Stanford, CA
Embryonic stem cells offer
incredible promise for treating diseases affecting both
children and adults. This mini course will provide an overview
of stem cells and a basic understanding of how to derive human
embryonic stem cells, recent research and ethical
considerations. After attending this session, attendee will
have a better understanding of: 1) what are embryonic stem
cells; 2) how human embryonic stem cells are derived; 3)
recent progress in human embryonic stem cell research; 4)
ethical considerations in human embryonic stem cells.
-
Stem Cells: Embryonic, Adult and
Cancer
Michael T. Longaker, Stanford University, Stanford, CA
-
What It Takes Clinically To Get
an Embryonic Stem Cell
Linda C. Giudice, University of California, San Francisco, San
Francisco, CA
-
What Can You Do with an Embryonic
Stem Cell in Research
Renee Reijo Pera, University of California, San Francisco, San
Francisco, CA
-
Ethical and Oversight
Considerations in Human Embryonic Stem Cell Research
Hank Greely, Stanford University, Stanford, CA
-
Panel Discussion
Supported in part by an unrestricted educational grant from
Treuman Katz Center for Pediatric Bioethics - Seattle
Children's Hospital
12:30pm–2:30pm
2540—Neonatal Infections
PAS Platform Session
Room 3003-3005, Moscone West
Chairs: Henrietta S. Bada and Jill E. Baley
1:00pm–3:00pm
2610—Genetics and Epigenetics of Neonatal
Disease
PAS Platform Session
Room 3022, Moscone West
Chairs: Aaron Hamvas and Jeffrey C. Murray
1:00pm–3:00pm
2630—Neurology
PAS Platform Session
Room 3020, Moscone West
Chairs: Anne M. Comi and Yvonne W. Wu
1:00pm–3:00pm
2635—Respiratory Mechanics at the
Bedside—NICU
PAS Platform Session
Room 3002-3008, Moscone West
Chairs: Robert E. Fleming and Howard W. Kilbride
2:15pm–5:15pm
2700—Educating Pediatric Fellows in a
Competency-Based World
PAS/APPD Mini Course
Room 2007, Moscone West
Chairs: Susan Guralnick, Stony Brook University Medical Center, Stony
Brook, NY; and Joseph Gilhooly, Oregon Health and Science
University, Portland, OR
Target Audience: Attendees
involved with fellowship programs.
Competency-based education is now
the standard for residency education. Residency programs have
integrated the ACGME Core Competencies into their curricula
and assessment methods. It is now time for fellowships to
enter the “competency” arena, and there is much to be
accomplished. This program will focus on several areas of
fellowship education including: the new RRC common
requirements for subspecialty training, development of a
competency-based fellowship curriculum, competency-based
assessment tools, and pediatric subspecialty fellows as
teachers. Attendees are encouraged to bring tools and ideas
for discussion and development. Attendees should leave with
useful materials to bring back to their home programs.
-
Overview
Susan Guralnick, Stony Brook University Medical Center, Stony Brook, NY
Joseph Gilhooly, Oregon Health
& Science University, Portland, OR
-
A Brave New World! New Common
Requirements for Subspecialty Training—Implementing the
Competencies
Carol Carraccio, Professor of Pediatrics and Associate Chair for
Education, University of Maryland School of Medicine,
Baltimore, MD
-
"Survivor ACGME"—Fellowship
Competencies in Action
Joseph Gilhooly, Oregon Health & Science University, Portland, OR
John D. Mahan, Children’s
Hospital, The Ohio State University, Columbus, OH
-
Turning to Fellows as Teachers:
From Curricula to Evaluation
Nancy D. Spector, St. Christopher's Hospital for Children,
Philadelphia, PA
Susan Guralnick, Stony Brook
University Medical Center, Stony Brook, NY
Sponsored jointly by
the Association of Pediatric Program Directors and the
Pediatric Academic Societies
Supported by an unrestricted
educational grant from Dey, L.P.
3:15pm–5:15pm
2725—Integrating Genetic Susceptibility and
Environmental Influences in Pediatric Research
PAS Topic Symposium
Room 2008, Moscone West
Chair: Bruce P. Lanphear, Cincinnati Children's Environmental Health
Center, Cincinnati Children’s Hospital Medical Center,
Cincinnati, OH
Target Audience: A broad
pediatric audience with the goal of promoting
interdisciplinary understanding and greater integration of
genetic and environmental research.
Asthma, preterm birth, ADHD and
other prevalent pediatric conditions are widely recognized to
result from interactions of environmental influences and
genetic susceptibility. Tremendous progress has been made in
measuring both environmental and genetic risk factors.
Increasingly, researchers are moving beyond ecological methods
(e.g., questionnaires, air monitoring) to directly measure in
humans hundreds of environmental chemicals, from nicotine to
metals to DDT and phthalates. Similarly, unprecedented
innovation has led rapidly to high-throughput methods that
assess DNA variation across large cohorts. New
interdisciplinary collaborations that integrate state of the
art approaches to both environmental and genetic influences
should greatly improve our ability to predict and prevent
disease and disability. Such studies will be critical for
understanding mechanistic pathways, defining susceptible
subpopulations and developing effective interventions. This
session will provide an overview of gene–environment
research, describe recent advances in biomarkers of
environmental exposure and review new methods for measuring
genetic variability.
-
Gene–Environment Interaction in
Common Pediatric Conditions: Conceptual Overview and
Recent Evidence
Robert S. Kahn, Cincinnati Children’s Hospital Medical Center,
University of Cincinnati College of Medicine, Cincinnati,
OH
-
Advances in Biomarkers of
Environmental Exposure in Pediatric Research
Bruce P. Lanphear, Cincinnati Children's Environmental Health Center,
Cincinnati Children’s Hospital Medical Center,
Cincinnati, OH
-
Measuring Genetic Susceptibility
to the Environment: Study Designs and Genotyping Methods
Robert O. Wright, Harvard Children's Environmental Health Center,
Boston Children's Hospital and the Harvard School of
Public Health, Boston, MA
3:15pm–5:15pm
2730—Mechanisms of Hypertension in the
Molecular Era
PAS/ASPN/IPHA/LWPES Topic Symposium
Room 2003-2005, Moscone West
Chairs: Bruce Z. Morgenstern, Phoenix Children's Hospital, Phoenix, AZ;
and Julie R. Ingelfinger, Massachusetts General Hospital,
Boston, MA
Target Audience: General
pediatricians, nephrologists, endocrinologists and
neonatologists.
Our understanding of the
pathophysiology of hypertension has been changing rapidly due
to advances in molecular genetics, most notably the
identification of several single-gene defects that cause
hypertension. This session will update participants on the
latest advances in our knowledge of molecular mechanisms of a
variety of forms of hypertension.
-
Role of Dopamine Receptors
Pedro A. Jose, Georgetown University Medical Center, Washington, DC
-
Perinatal Programming and the
Development of Hypertension
Lori Woods, Oregon Health & Science University, Portland, OR
-
Low Renin Hypertension in
Childhood
Maria I. New, Mount Sinai School of Medicine, New York, NY
-
WNK Kinases and Blood Pressure
Regulation
Richard Lifton, Yale University School of Medicine, New Haven, CT
Sponsored jointly by
the American Society of Pediatric Nephrology, the
International Pediatric Hypertension Association, the Lawson
Wilkins Pediatric Endocrine Society and the Pediatric Academic
Societies
3:15pm–5:15pm
2751—Neonatal Fetal Nutrition and
Metabolism I
PAS Platform Session
Room 3022, Moscone West
Chairs: David H. Adamkin and Ronnie Guillet
3:15pm–5:15pm
2753—Neonatal Infectious Diseases
PAS/PIDS Poster Symposium
Room 3003-3005, Moscone West
Chairs: Deborah A. Lewinsohn and John V. Williams
3:15pm–5:15pm
2755—Neonatal Medicine: Clinical Trials I
PAS Platform Session
Room 3002-3008, Moscone West
Chairs: Namasivayam Ambalavanan and Reese H. Clark
3:15pm–5:15pm
2757—Nutrition and Behavior
PAS Poster Symposium
Room 3024, Moscone West
Chairs: Conrad R. Cole and Timothy A. Sentongo
3:15pm–5:15pm
2768—So You Want To Do International
Research?
PAS Educational Workshop
Golden Gate Hall B1, SF Marriott
Leader: Linda Wright, Rockville, MD; Co-leaders: Jose Belizan, Waldemar
Carlo, Jeanne McDermott, Elizabeth McClure and Cyril Engmann
Target Audience: Trainees,
fellows, junior faculty, and mid-level faculty.
Almost all (99%) of maternal and
infant deaths worldwide occur in low and middle-income
countries. Conducting research in these countries has many
rewards and challenges, which are often daunting for
investigators trying to apply for NIH support. This workshop
will describe the process of applying for research support
from NIH, how review is done and funding decisions made, how
to enhance the likelihood of success and NIH's priorities for
research. We will also discuss the design and conduct of
studies in these settings, how to identify appropriate partner
countries and collaborate with local investigators and
government organizations as well as how to address three
important areas for international research, strengthening
local research capacity, scaling up proven interventions, and
facilitating sustainability.
Objectives:
– To increase participants
understanding of issues related to the design and
implementation of clinical trials in low and middle-income
countries
– To increase participants skills in writing a protocol for
research in another country
– To increase participants knowledge of funding
opportunities for research in low and middle-income countries
Format: The format will be
didactic presentations with extensive question-and-answer
session.
3:45pm–5:15pm
2790A—Hyperthyroidism
LWPES Workshop
Room 3000, Moscone West
Chair: Scott A. Rivkees, Yale School of Medicine, New Haven, CT
Target Audience: Generalists.
Much controversy exists about the
most effective and safest treatments for hyperthyroidism in
children. This workshop will clarify some of the newer
evidence based approaches to the diagnosis and management of
hyperthyroidism, with a special emphasis on radioactive
ablation.
3:45pm–5:15pm
2795A—Neonatal Diabetes
LWPES Workshop
Room 3001, Moscone West
Chair: Mark A. Sperling, Children's Hospital of Pittsburgh, Pittsburgh,
PA
Target Audience: Endocrinologists
and neonatologists.
Over the past few years much has
been learned about the pathogenesis of neonatal diabetes. This
workshop will impart knowledge on important considerations in
the diagnosis and work-up of this rare condition.
4:00pm–7:30pm
Commercial Exhibits Open and Posters
Available for Viewing
PAS Exhibits
Levels 1 and 2, Moscone West
Posters Available for Viewing:
4:00pm–7:30pm
Author Attendance: 5:15pm–7:15pm
Level 1:
– Developmental Biology
– Endocrinology
– Hematology–Oncology
– Neonatal Infectious Diseases
– Neonatology
– Nephrology
Level 2:
– Cardiology
– Developmental–Behavioral Pediatrics
– General Pediatrics
– Medical Education
– Neurology
5:15pm–7:15pm
Poster Session I and PAS Opening Reception
PAS Poster Session
Levels 1 and 2, Moscone West
Posters Available for Viewing:
4:00pm–7:30pm
Author Attendance: 5:15pm–7:15pm
Level 1:
– Developmental Biology
– Endocrinology
– Hematology–Oncology
– Neonatal Infectious Diseases
– Neonatology
– Nephrology
Level 2:
– Cardiology
– Developmental–Behavioral Pediatrics
– General Pediatrics
– Medical Education
– Neurology
Includes:
-
SPR Student Research Award:
Resuscitation of Non-Viable Infants: Will Neonatologists'
Practice Change After the Born-Alive Infant Protection
Act?
Mya Sendowski, University of California, San Francisco, CA
7:15pm–8:30pm
2960A—Neonatal Hemodynamics Club
Club
Golden Gate Hall A1-3, SF Marriott
-
Relative Adrenal Insufficiency in
the Preterm and Term Infant
Kristi L. Watterberg, University of New Mexico Health Sciences Center,
Albuquerque, NM
-
Cardiac Function and Its
Relationship to Serum Cortisol, Inflammation, Pulmonary
Acuity and Hydrocortisone Therapy in Sick ELBW Infants
Cynthia H. Cole, Harvard Medical School, Boston, MA
-
Discussion
Istvan Seri, MD, PhD
Children’s Hospital Los Angeles, University of Southern
California
Phone: 323-669-5932
Email: iseri@chla.usc.edu
Supported by an unrestricted educational grant from Dey LP
Sunday, April 30
6:00am–8:00am
Surfactant Therapy—Where Are We and Where
Do We Go from Here?
PAS Industry Sponsored Symposium
Yerba Buena Gardens Salon 8, SF Marriott
Target Audience: Neonatologists.
Respiratory distress syndrome (RDS)
results from insufficient levels of endogenous surfactant.
Surfactant therapy, when used as treatment or prophylaxis,
significantly reduces morbidity and mortality. New synthetic
protein-containing products promise to emerge soon as a viable
therapeutic strategy in the prevention of RDS. Neonatologists
and other pediatric health care professionals need to have a
thorough and up-to-date understanding of current and emerging
products to make the most informed clinical decisions for
their patients.
This symposium will focus on the
current role of exogenous surfactant therapy in neonatology.
Speakers will review the composition and function of this
class of compounds. Faculty also will discuss the clinical
status of current animal-derived and future protein-containing
synthetic surfactant therapies, including comparative trials
and meta-analyses, as well as studies of various ventilation
strategies in conjunction with surfactant therapy.
Additionally, speakers will describe potential new
applications of surfactant therapy.
For information please contact:
(Please note that pre-registration is not required)
Danielle Krasny
Phone: (215) 860-2202
Email: danielle.krasny@thomson.com
This activity is
jointly sponsored by Thomson Professional Postgraduate Service
and Thomson Scientific Connexions
Supported
by a grant from Discovery Laboratories, Inc.
7:00am–8:00am
3045—Neonatology:
There Are Many Ways to Get to Rome (or Omaha or…)
PAS Meet the Professor
Yerba Buena Gardens Salon 10, SF Marriott
This interactive session will
explore the proposition that the route that one chooses to
success in an academic environment is less important than the
way one makes the journey. The important principles of making
the trip are simple. They are easier to measure than to
master.
8:00am–10:00am
3110—Probiotics in Necrotizing
Enterocolitis—Their Clinical Effect and Possible Mechanisms
PAS/ASPR/JPS/NASPGHAN Topic Symposium
Room 3003-3005, Moscone West
Chairs: W. Allan Walker, Harvard Medical School, Boston, MA; and
Yuichiro Yamashiro, Juntendo University School of Medicine,
Tokyo, Japan
Target Audience: Neonatologists,
gastroenterologists, pediatric surgeons, NICU nurses and
bacteriologists in perinatal medicine.
Necrotizing enterocolitis (NEC)
is a serious gastrointestinal disease seen predominantly in
very low birth weight (VLBW) and extremely low birth weight (ELBW)
infants. NEC is probably a complex, multifactorial disease.
Currently, the precise pathogenic mechanisms remain to be
elucidated; however, clinical use of probiotics has been
reported to be useful for preventing NEC development in VLBW
and ELBW infants. This session will provide us the current
knowledge about the role of probiotics in the management of
NEC.
-
Fifteen-Year's Experience of
Early Administration of Bifidobacterium Breve to Preterm
Infants
H. Kitajima, Osaka Medical Center and Research Institute for Maternal
and Child Health, Osaka, Japan
-
Oral Probiotics Reduces Incidence
of NEC in VLBW Infants
H. C. Lin, China Medical University, Taichung, Taiwan
-
Effects of Probiotics on the
Immunological Development and Short Chain Fatty Acids in
ELBW and VLBW Infants
Yoshikazu Ohtsuka, Juntendo University School of Medicine, Bunkyo-ku,
Japan
-
Possible Role of Probiotic
Supplementation for Prevention from NEC
Michael S. Caplan, Northwestern University, Evanston, IL
Sponsored jointly by
the Asian Society for Pediatric Research; Japan Pediatric
Society; North American Society for Pediatric
Gastroenterology, Hepatology & Nutrition and the Pediatric
Academic Societies
8:00am–10:00am
3125—Developmental Origins of Adult
Disease—Metabolism
PAS Platform Session
Room 3010-3012, Moscone West
Chairs: William W. Hay and Rebecca A. Simmons
8:00am–10:00am
3153—Late-Breaker Abstract Session I:
Clinical Trials in Neonatology
PAS Platform Session
Room 3022-3024, Moscone West Convention Center
Chairs: Lucky Jain and Robin H. Steinhorn
The "Late-Breaker"
sessions will include reports on clinical trials and other
important and significant pediatric research, which might not
have been ready for reporting at the time of the winter
abstract deadline. There are two sessions during the meeting.
Session II is on Monday, May 1, from 10:15am to 12:15pm. The
sessions will include presentations in the areas of
noenatology, basic science and clinical research in several
clinical areas. Please be sure to review the content so you
don't miss these very special sessions!
The abstracts selected for this
session were not available at press time, but are included as
a separate piece with this program, onsite from the
Information Desk on Level 1 of Moscone West, and are also
posted on the PAS website at www.pas-meeting.org (after April
1).
10:15am–12:00pm
3350—APS Presidential Plenary and Awards
APS Presidential Plenary
Room 3002-3008, Moscone West
Chair: David K. Stevenson, Stanford University School of Medicine, Palo
Alto, CA
*The Joseph W. St. Geme, Jr.
Leadership Award is presented by the Federation of Pediatric
Organizations on behalf of the Ambulatory Pediatric
Association, American Academy of Pediatrics, American Board of
Pediatrics, American Pediatric Society, Association of Medical
School Pediatric Department Chairmen, Association of Pediatric
Program Directors and Society for Pediatric Research.
-
2006 APS Presidential Address
David K. Stevenson, Harold K. Faber Professor of Pediatrics, Vice Dean
and Senior Associate Dean for Academic Affairs, Stanford
University School of Medicine; Director, Charles B. and
Ann L. Johnson Center for Pregnancy and Newborn Services;
Chief, Division of Neonatal and Developmental Medicine,
Lucile Packard Children's Hospital at Stanford, Palo Alto,
CA
-
New Member Outstanding Science
Award—Epithelial Branching and the Origins of Kidney
Malformation
Norman D. Rosenblum, Professor of Paediatrics and Canada Research Chair
in Developmental Nephrology, Division of Nephrology &
Program in Developmental Biology, The Hospital for Sick
Children, Toronto, Ontario, Canada
-
Introduction, John Howland
Awardee
Frederick J. Suchy, Herbert H. Lehman Professor of Pediatrics and
Chair, Department of Pediatrics, Mount Sinai School of
Medicine, New York, NY
-
54th Annual John Howland Award
Kurt Hirschhorn, Professor of Pediatrics, Human Genetics and Medicine,
Chairman Emeritus, Department of Pediatrics, Mount Sinai
School of Medicine, New York, NY
-
Introduction, Joseph W. St. Geme,
Jr. Leadership Award
Carol Carraccio, Professor of Pediatrics and Associate Chair for
Education, University of Maryland School of Medicine,
Baltimore, MD
-
Joseph W. St. Geme, Jr.
Leadership Award*
Carol D. Berkowitz, Professor of Clinical Pediatrics, David Geffen
School of Medicine at UCLA, Torrance, CA
11:00am–4:00pm
Commercial Exhibits Open and Posters
Available for Viewing
PAS Exhibits
Levels 1 and 2, Moscone West
Posters Available for Viewing:
11:00am–4:00pm
Author Attendance: 12:00pm–2:00pm
Level 1:
– Allergy, Immunology and Rheumatology
– Developmental-Behavioral Pediatrics
– Endocrinology
– Infectious Diseases
– General Pediatrics
– Hematology–Oncology
Level 2:
– Cardiology
– Neonatal Neurology
– Neonatology
12:00pm–1:30pm
3440A—Perinatal Brain Club
Hypothermia as a Neuroprotective Strategy in Term Infants
Club
Room 3022-3024, Moscone West
-
Introduction
Jeffrey M. Perlman, Weill Cornell Medical College, New York, NY
-
Hypothermia and Neuroprotection—Future
Strategies Based on Experimental Observations
Marianne Thoresen, University of Bristol, Bristol, England, UK
-
Hypothermia as a Neuroprotective
Strategy—Translating Science into Clinical Practice:
What Are the Hidden Obstacles?
Lu-Ann Papile, University of New Mexico Health Science Center,
Albuquerque, New Mexico
-
Discussion
Contact for information:
Jeff Perlman, MD
Weill Cornell Medical College
Phone: 212-746-3533
Email: jmp2007@med.cornell.edu
12:00pm–2:00pm
Poster Session II
PAS Poster Session
Levels 1 and 2, Moscone West
Posters Available for Viewing:
11:00am–4:00pm
Author Attendance: 12:00pm–2:00pm
Level 1:
– Allergy, Immunology and Rheumatology
– Developmental-Behavioral Pediatrics
– Endocrinology
– Infectious Diseases
– General Pediatrics
– Hematology–Oncology
Level 2:
– Cardiology
– Neonatal Neurology
– Neonatology
Includes:
-
SPR Fellow's Basic Research
Award: Myopalladin Mutations and Inherited
Cardiomyopathies
Enkhsaikhan Purevjav, Baylor College of Medicine, Houston, TX
-
SPR Clinical Research Award:
Accelerated Development in the Visual Areas of Preterm
Infants? A Voxel-Based Morphometry Study on Diffusion
Tensor MR Imaging (DTI)
Maria Miranda, Copenhagen University Hospital, Hvidovre, Denmark
-
SPR Fellow's Clinical Research
Award: Novel Genotyping Technology To Classify Childhood
Leukemia
Joshua D. Schiffman, Stanford University, Palo Alto, CA
-
SPR House Officer Research Award:
Erythropoietin Protein Expression in the Developing Human
Eye
Shrena Patel, University of New Mexico, Albuquerque, NM
2:00pm–4:00pm
3705—Infections at the
Maternal–Placental–Fetal Interface: Immunopathogenesis of
Group B Streptococcus, Listeria monocytogenes and
Cytomegalovirus
PAS/PIDS Topic Symposium
Room 3022-3024, Moscone West
Chairs: John R. Schreiber, University of Minnesota Medical School and
University of Minnesota Children's Hospital/Fairview,
Minneapolis, MN; and Robert F. Pass, University of Alabama at
Birmingham, Birmingham, AL
Target Audience: Neonatologists,
infectious disease specialists, immunologists, developmental
biologists and general pediatricians.
Infections in newborns commonly
result from acquisition either during the delivery process or
transplacentally. The host and pathogen factors that
contribute to acquisition of infections at the
maternal–placental–fetal interface are poorly understood.
This symposium will review the basic science and
immunopathogenesis of three diverse pathogens that all share
the ability to cause infections at the placental level:
cytomegalovirus, group B streptococcus, and Listeria
monocytogenes.
-
Intrauterine Cytomegalovirus
Infection, Transplacental Spread of Virus and Control by
Maternal Immunity
Lenore Pereira, University of California San Francisco, San Francisco,
CA
-
Host and Bacterial Factors in
Invasive Group B Streptococcal Infection
Craig E. Rubens, University of Washington, Seattle, WA
-
Listeriosis in the Pregnant
Guinea Pig: A Model of Vertical Transmission
Daniel A. Portnoy, University of California Berkeley, Berkeley, CA
-
Discussion
Sponsored jointly by
the Pediatric Infectious Diseases Society and the Pediatric
Academic Societies
2:00pm–4:00pm
3718—Fetal Origins of Adult Disease
PAS Poster Symposium
Room 3001, Moscone West
Chairs: David W. Boyle and Jeffrey L. Segar
2:00pm–4:00pm
3722—Neonatal Lung Inflammation: Mechanisms
and Clinical Implications
PAS Platform Session
Room 3014, Moscone West
Chairs: Rose M. Viscardi and Stephen E. Welty
Supported by an unrestricted educational grant from Dey,
L.P.
2:00pm–4:00pm
3724—Neonatal Medicine: Clinical Trials II
PAS Platform Session
Room 3002-3008, Moscone West
Chairs: Ricki F. Goldstein and Robert M. Ward
2:00pm–4:00pm
3726—Neonatal Neurology: MRI and aEEG in
the NICU
PAS Poster Symposium
Room 3020, Moscone West
Chairs: Linda S. de Vries and Terrie E. Inder
2:00pm–4:00pm
3732—Pulmonary and Cardiac Development:
Transcriptional Control and Stem Cells
PAS Platform Session
Room 2004, Moscone West
Chairs: Lawrence M. Nogee and George A. Porter
Includes:
-
SPR Student Research Award:
Critical Requirement of C/EBP[alpha] for Lung Maturation
and Function
Prithy Martis, Cincinnati Children's Hospital Medical Center,
Cincinnati, OH
2:00pm–5:00pm
3740—AAP Presidential Plenary and First
Annual Silverman Lecture
AAP Presidential Plenary
Room 3007-3011, Moscone West
Chair: Errol R. Alden, American Academy of Pediatrics, Elk Grove
Village, IL
Target Audience: Scientists and
clinicians interested in the translation of research and
evidence-based principles into health policy and practice.
-
AAP Presidential Address
Eileen M. Ouellette, President, American Academy of Pediatrics, Elk
Grove Village, IL
-
The Community Pediatrics Training
Initiative: Quality Resident Education in Community
Pediatrics
Jeffrey M. Kaczorowski, University of Rochester, Strong Memorial
Hospital, Rochester, NY
-
The Scientific Underpinnings of
Preventive Services for Children: The Bright Futures
Project
Paula M. Duncan, University of Vermont, Burlington, VT
-
The Evidence Base Underlying
Pay-for-Performance Initiatives
Paul V. Miles, The American Board of Pediatrics, Chapel Hill, NC
-
First Annual William A. Silverman
MD Lecture:
From Disasters to Triumphs—Lessons Learned in the
Evolution of Neonatology as a Subspecialty
Avroy A. Fanaroff, Case Western Reserve University School of Medicine,
Cleveland, OH
The Silverman Lecture
is sponsored by the AAP Section on Perinatal Pediatrics
2:00pm–5:00pm
3765—High-Fidelity Pediatric Simulation:
Setting a National Human Performance and Patient Safety
Research and Training Agenda
PAS Educational Workshop
Yerba Buena Gardens Salon 2, SF Marriott
Leader: Louis Halamek, Palo Alto, CA; Co-leaders: Mary Patterson,
Joseph Lopreiato
Target Audience: Trainees,
fellows, junior faculty, and mid-level faculty, senior
faculty.
|
